Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BASILIXIMAB Cause Graft versus host disease? 111 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Graft versus host disease have been filed in association with BASILIXIMAB (Simulect). This represents 1.6% of all adverse event reports for BASILIXIMAB.

111
Reports of Graft versus host disease with BASILIXIMAB
1.6%
of all BASILIXIMAB reports
72
Deaths
45
Hospitalizations

How Dangerous Is Graft versus host disease From BASILIXIMAB?

Of the 111 reports, 72 (64.9%) resulted in death, 45 (40.5%) required hospitalization, and 13 (11.7%) were considered life-threatening.

Is Graft versus host disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BASILIXIMAB. However, 111 reports have been filed with the FAERS database.

What Other Side Effects Does BASILIXIMAB Cause?

Cytomegalovirus infection (590) Drug ineffective (567) Off label use (567) Transplant rejection (554) Kidney transplant rejection (456) Product use in unapproved indication (428) Pyrexia (323) Diarrhoea (314) Multiple organ dysfunction syndrome (298) Polyomavirus-associated nephropathy (298)

What Other Drugs Cause Graft versus host disease?

CYCLOSPORINE (1,131) TACROLIMUS (900) MYCOPHENOLATE MOFETIL (890) CYCLOPHOSPHAMIDE (653) METHOTREXATE (615) FLUDARABINE (541) BUSULFAN (507) RUXOLITINIB (469) METHYLPREDNISOLONE (429) PREDNISONE (405)

Which BASILIXIMAB Alternatives Have Lower Graft versus host disease Risk?

BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED BASILIXIMAB vs BCG VACCINE BASILIXIMAB vs BEBTELOVIMAB BASILIXIMAB vs BECLOMETHASONE

Related Pages

BASILIXIMAB Full Profile All Graft versus host disease Reports All Drugs Causing Graft versus host disease BASILIXIMAB Demographics